{
    "id": "dbpedia_7675_2",
    "rank": 65,
    "data": {
        "url": "https://www.shangbaycapital.com/mike-wallace",
        "read_more_link": "",
        "language": "en",
        "title": "shangbay-capital",
        "top_image": "https://static.parastorage.com/client/pfavico.ico",
        "meta_img": "https://static.parastorage.com/client/pfavico.ico",
        "images": [
            "https://static.wixstatic.com/media/751c27_a97b40bd16b54ed48d6274be2c1de37f~mv2.png/v1/fill/w_289,h_66,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Shangbay%202019%20Logo.png",
            "https://static.wixstatic.com/media/751c27_0919ae713f16427a821268f7f95eb6a4~mv2.jpg/v1/crop/x_12,y_0,w_852,h_875/fill/w_290,h_298,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/Mike%20B%26W.jpg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "https://static.parastorage.com/client/pfavico.ico",
        "meta_site_name": "shangbay-capital",
        "canonical_link": "https://www.shangbaycapital.com/mike-wallace",
        "text": "Mike is a medical device executive and serial entrepreneur with over 25 years of experience, inventor of over 130 issued U.S patents, and a passion for purposeful innovation to help patients. Mike holds a BSME from the University of Delaware and a Masters In Mechanical Engineering from UC Davis.\n\n​\n\nHis 4th startup, DeVoro Medical, was acquired by Boston Scientific in 2021 for a total value of $400M. DeVoro is focused on disrupting the growing peripheral thrombectomy space with its novel WOLF thrombectomy platform.\n\n​\n\nMike has also been fortunate to be part of 3 other successful startup exits that he Co-founded: TW Medical - a neurovascular intra aneurysmal solution acquired by Stryker, GW Medical Neuro WOLF Solution- acquired by Stryker and CardioProlific – a Peripheral Vascular solutions company acquired by Philips. Mike was previously the CTO & VP Operations of Silk Road Medical (NASDAQ: SILK), Exec VP of R&D and Operations at Baxano, VP of R&D at Boston Scientific (Neuro Vascular and Electrophysiology Divisions), VP of R&D at BarrX Medical, and an R&D Manager at Target Therapeutics."
    }
}